IBDEI24E ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35957,1,3,0)
 ;;=3^Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,35957,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,35957,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,35958,0)
 ;;=L40.2^^134^1738^1
 ;;^UTILITY(U,$J,358.3,35958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35958,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,35958,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,35958,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,35959,0)
 ;;=L03.91^^134^1738^2
 ;;^UTILITY(U,$J,358.3,35959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35959,1,3,0)
 ;;=3^Acute Lymphangitis,Unspec
 ;;^UTILITY(U,$J,358.3,35959,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,35959,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,35960,0)
 ;;=L23.9^^134^1738^3
 ;;^UTILITY(U,$J,358.3,35960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35960,1,3,0)
 ;;=3^Allergic Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,35960,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,35960,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,35961,0)
 ;;=L03.90^^134^1738^4
 ;;^UTILITY(U,$J,358.3,35961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35961,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,35961,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,35961,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,35962,0)
 ;;=L02.91^^134^1738^7
 ;;^UTILITY(U,$J,358.3,35962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35962,1,3,0)
 ;;=3^Cutaneous Abscess,Unspec
 ;;^UTILITY(U,$J,358.3,35962,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,35962,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,35963,0)
 ;;=L30.2^^134^1738^8
 ;;^UTILITY(U,$J,358.3,35963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35963,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,35963,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,35963,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,35964,0)
 ;;=L30.9^^134^1738^10
 ;;^UTILITY(U,$J,358.3,35964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35964,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,35964,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,35964,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,35965,0)
 ;;=Z48.01^^134^1738^5
 ;;^UTILITY(U,$J,358.3,35965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35965,1,3,0)
 ;;=3^Change/Removal of Surgical Wound Dressing
 ;;^UTILITY(U,$J,358.3,35965,1,4,0)
 ;;=4^Z48.01
 ;;^UTILITY(U,$J,358.3,35965,2)
 ;;=^5063034
 ;;^UTILITY(U,$J,358.3,35966,0)
 ;;=L98.3^^134^1738^11
 ;;^UTILITY(U,$J,358.3,35966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35966,1,3,0)
 ;;=3^Eosinophilic Cellulitis
 ;;^UTILITY(U,$J,358.3,35966,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,35966,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,35967,0)
 ;;=L40.1^^134^1738^18
 ;;^UTILITY(U,$J,358.3,35967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35967,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,35967,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,35967,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,35968,0)
 ;;=L40.4^^134^1738^12
 ;;^UTILITY(U,$J,358.3,35968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35968,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,35968,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,35968,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,35969,0)
 ;;=L24.9^^134^1738^13
 ;;^UTILITY(U,$J,358.3,35969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35969,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,35969,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,35969,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,35970,0)
 ;;=L30.0^^134^1738^14
 ;;^UTILITY(U,$J,358.3,35970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35970,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,35970,1,4,0)
 ;;=4^L30.0
